COMBINED BROMOCRIPTINE-LEVODOPA THERAPY EARLY IN PARKINSONS-DISEASE

被引：144
|
作者：
RINNE, UK
机构：
来源：
NEUROLOGY | 1985年 / 35卷 / 08期
关键词：
D O I：
10.1212/WNL.35.8.1196
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1196 / 1198
页数：3
相关论文
共 50 条
  • [1] BROMOCRIPTINE COMBINED WITH LEVODOPA IN PARKINSONS-DISEASE
    GAUTHIER, G
    DASILVA, AM
    EUROPEAN NEUROLOGY, 1982, 21 (04) : 217 - 226
  • [2] EARLY COMBINATION THERAPY WITH BROMOCRIPTINE AND LEVODOPA IN PARKINSONS-DISEASE
    FACTOR, SA
    WEINER, WJ
    MOVEMENT DISORDERS, 1993, 8 (03) : 257 - 262
  • [3] BROMOCRIPTINE IN LIEU OF LEVODOPA FOR PARKINSONS-DISEASE
    WODAK, J
    STARK, R
    GILLIGAN, B
    MEDICAL JOURNAL OF AUSTRALIA, 1978, 2 : 28 - 31
  • [4] EARLY COMBINATION THERAPY (BROMOCRIPTINE AND LEVODOPA) DOES NOT PREVENT MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE
    WEINER, WJ
    FACTOR, SA
    SANCHEZRAMOS, JR
    SINGER, C
    SHELDON, C
    CORNELIUS, L
    INGENITO, A
    NEUROLOGY, 1993, 43 (01) : 21 - 27
  • [5] THE INFLUENCE OF LEVODOPA IN THE PHARMACOKINETICS OF BROMOCRIPTINE IN PARKINSONS-DISEASE
    RABEY, JM
    OBERMAN, Z
    SCHARF, M
    ISAKOV, A
    BAR, M
    GRAFF, E
    CLINICAL NEUROPHARMACOLOGY, 1989, 12 (05) : 440 - 447
  • [6] THE INFLUENCE OF BROMOCRIPTINE ON THE PHARMACOKINETICS OF LEVODOPA IN PARKINSONS-DISEASE
    RABEY, JM
    SCHWARTZ, M
    GRAFF, E
    HARSAT, A
    VERED, Y
    CLINICAL NEUROPHARMACOLOGY, 1991, 14 (06) : 514 - 522
  • [7] COMPARISON OF EFFECTS OF BROMOCRIPTINE AND LEVODOPA IN PARKINSONS-DISEASE
    GODWINAUSTEN, RB
    SMITH, NJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1977, 40 (05): : 479 - 482
  • [8] EARLY TREATMENT WITH A COMBINATION OF BROMOCRIPTINE AND LEVODOPA COMPARED WITH LEVODOPA MONOTHERAPY IN THE TREATMENT OF PARKINSONS-DISEASE
    OLSSON, JE
    RASCOL, A
    KORTEN, JJ
    DUPONT, E
    GAUTHIER, G
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 46 (05): : 1002 - 1014
  • [9] RESULT OF CHRONIC LEVODOPA THERAPY AND ITS MODIFICATION BY BROMOCRIPTINE IN PARKINSONS-DISEASE
    HOEHN, MMM
    ACTA NEUROLOGICA SCANDINAVICA, 1985, 71 (02): : 97 - 106
  • [10] NO EFFECT OF CHRONIC BROMOCRIPTINE THERAPY ON LEVODOPA PHARMACOKINETICS IN PATIENTS WITH PARKINSONS-DISEASE
    CONTIN, M
    RIVA, R
    MARTINELLI, P
    ALBANI, F
    BARUZZI, A
    CLINICAL NEUROPHARMACOLOGY, 1992, 15 (06) : 505 - 508
12345